MYIA
GMAB icon

Mount Yale Investment Advisors’s Genmab GMAB Stock Holding History

Mount Yale Investment Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-280
Closed -$5.79K – 1043
2025
Q2 		$5.79K Buy
+280
New +$5.75K ﹤0.01% 1215
2024
Q4 		– Sell
-7,883
Closed -$192K – 583
2024
Q3 		$192K Buy
+7,883
New +$211K 0.02% 525
2024
Q2 		– Sell
-9,113
Closed -$273K – 558
2024
Q1 		$273K Buy
+9,113
New +$268K 0.02% 474
2023
Q4 		– Sell
-6,390
Closed -$225K – 518
2023
Q3 		$225K Sell
6,390
-1,435
-18% -$54.7K 0.02% 454
2023
Q2 		$297K Sell
7,825
-6,717
-46% -$268K 0.03% 392
2023
Q1 		$549K Sell
14,542
-3,974
-21% -$153K 0.06% 287
2022
Q4 		$785K Sell
18,516
-3,775
-17% -$156K 0.09% 227
2022
Q3 		$716K Buy
22,291
+9,461
+74% +$332K 0.1% 221
2022
Q2 		$417K Sell
12,830
-20,120
-61% -$652K 0.05% 309
2022
Q1 		$1.19M Sell
32,950
-4,199
-11% -$144K 0.13% 172
2021
Q4 		$1.47M Sell
37,149
-5,038
-12% -$210K 0.15% 146
2021
Q3 		$1.84M Buy
42,187
+4,120
+11% +$185K 0.21% 113
2021
Q2 		$1.55M Buy
38,067
+15,243
+67% +$588K 0.19% 119
2021
Q1 		$749K Sell
22,824
-11,840
-34% -$445K 0.1% 217
2020
Q4 		$1.41M Sell
34,664
-9,172
-21% -$343K 0.2% 113
2020
Q3 		$1.6M Buy
43,836
+15,656
+56% +$566K 0.23% 98
2020
Q2 		$955K Buy
+28,180
New +$768K 0.17% 132

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mount Yale Investment Advisors's GMAB Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Genmab (GMAB) in Q3 2025, closing a stake of 280 shares — an estimated $5.79K sold.

Mount Yale Investment Advisors first reported a position in GMAB in Q2 2020 and held it in 17 quarters. The position peaked at $1.84M in Q3 2021. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 280 Genmab shares in Q3 2025, an estimated $5.79K.
  • Mount Yale Investment Advisors first reported a position in Genmab in Q2 2020 and held it in 17 quarters.
  • Mount Yale Investment Advisors's Genmab position peaked at $1.84M in Q3 2021.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.